524238 GUJINJEC

Gujarat Inject (Kerala) Share Price

 

 

Start SIP in GUJINJEC

Start SIP

Performance

  • Low
  • ₹33
  • High
  • ₹35
  • 52 Week Low
  • ₹17
  • 52 Week High
  • ₹35
  • Open Price₹34
  • Previous Close₹33
  • Volume97,019

Investment Returns

  • Over 1 Month + 19.72%
  • Over 3 Month + 72.23%
  • Over 6 Month + 40.73%
  • Over 1 Year + 49.96%

Smart Investing Starts Here Start SIP with Gujarat Inject (Kerala) for Steady Growth!

Invest Now

Gujarat Inject (Kerala) Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 118.9
  • PEG Ratio
  • -2.6
  • Market Cap Cr
  • 51
  • P/B Ratio
  • 5
  • Average True Range
  • 1.51
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 1.81
  • RSI
  • 78.12
  • MFI
  • 83.87

Gujarat Inject (Kerala) Financials

Gujarat Inject (Kerala) Technicals

EMA & SMA

Current Price
₹34.55
+ 1.29 (3.88%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹31.24
  • 50 Day
  • ₹28.07
  • 100 Day
  • ₹25.76
  • 200 Day
  • ₹23.77

Resistance and Support

34.17 Pivot Speed
  • R3 36.98
  • R2 35.92
  • R1 35.23
  • S1 33.48
  • S2 32.42
  • S3 31.73

Gujarat Inject (Kerala) Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-13 Quarterly Results
2025-08-14 Quarterly Results
2025-05-20 Audited Results
2025-02-18 Stock Split
2025-01-23 Quarterly Results

Gujarat Inject (Kerala) F&O

Gujarat Inject (Kerala) Shareholding Pattern

0%
92.83%
7.17%

Gujarat Inject (Kerala) FAQs

Gujarat Inject (Kerala) share price is ₹34 As on 28 December, 2025 | 07:39

The Market Cap of Gujarat Inject (Kerala) is ₹50.6 Cr As on 28 December, 2025 | 07:39

The P/E ratio of Gujarat Inject (Kerala) is 118.9 As on 28 December, 2025 | 07:39

The PB ratio of Gujarat Inject (Kerala) is 5 As on 28 December, 2025 | 07:39

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23